Rockwell Medical, Inc. (NASDAQ:RMTI) Q4 2022 Earnings Conference Call March 30, 2023 8:00 AM ET

Company Participants

Heather Hunter - Senior Vice President and Chief Corporate Affairs Officer

Mark Strobeck - President and Chief Executive Officer

Tim Chole - Senior Vice President, Sales and Marketing

Paul McGarry - Senior Vice President, Finance and Chief Accounting Officer

Conference Call Participants

Brandon Folkes - Cantor Fitzgerald

Operator

Good morning, and welcome to Rockwell Medical's Fourth Quarter and Full-Year 2022 Results Conference Call and Webcast. Please note, this event is being recorded.

At this time, I would like to turn the conference call over to Heather Hunter, Senior Vice President, Chief Corporate Affairs Officer at Rockwell Medical. Heather, please go ahead.

Heather Hunter

Good morning, and thank you for joining us for this update on Rockwell Medical. Joining me on today's conference call are Dr. Mark Strobeck, Rockwell Medical’s President and Chief Executive Officer; Tim Chole, Rockwell Medical's Senior Vice President, Sales and Marketing; and Paul McGarry, Rockwell Medical's Senior Vice President, Finance and Chief Accounting Officer.

Before we begin, I would like to remind you that this conference call will contain forward-looking statements about Rockwell Medical within the meaning of the federal securities laws including, but not limited to, the types of statements identified as forward-looking in our annual report on Form 10-K and our subsequent periodic reports filed with the SEC, which are all available on our website under the Investors section. These statements are subject to risks and uncertainties that could cause actual results to differ.

Please note that these forward-looking statements reflect our opinions and expectations only as of today. Except as required by law, we specifically disclaim any obligation to update or revise these forward-looking statements in-light of new information or future events. Factors that could cause actual results or outcomes to differ materially from those expressed in or implied by such forward-looking statements are discussed in greater detail in our periodic reports filed with the SEC.

Rockwell Medical's annual report on Form 10-K for the year ended December 31, 2022 was filed prior to this call and provides a full analysis of the company's business strategy, as well as the company's fourth quarter and full-year 2022 results. It can be found on Rockwell Medical's website under the Investors section along with today’s press release and a recording of this webcast.

Now, I would like to turn the conference call over to Rockwell Medical's President and CEO, Dr. Mark Strobeck.